LakeShore Biopharma Receives Revised Acquisition Offer Amid Financial Review LakeShore Biopharma has received a revised proposal to acquire outstanding shares at a reduced price, as the company navigates financial challenges.

LakeShore Biopharma Receives Revised Acquisition Offer Amid Financial Review #China #Beijing #LakeShore_Biopharma #Merger_Proposal #Oceanpine_Skyline

LakeShore Biopharma to Host Extraordinary General Meeting for Shareholders to Discuss Merger LakeShore Biopharma announces an extraordinary meeting on February 12, 2026, to discuss a significant merger agreement with Oceanpine Skyline Inc.

LakeShore Biopharma to Host Extraordinary General Meeting for Shareholders to Discuss Merger #China #Beijing #LakeShore_Biopharma #Extraordinary_Meeting #Oceanpine_Skyline

LakeShore Biopharma Announces Major Shift to Private Ownership Through Merger Agreement LakeShore Biopharma is set to go private following a merger agreement with Oceanpine Skyline. Shareholders to receive cash per share.

LakeShore Biopharma Announces Major Shift to Private Ownership Through Merger Agreement #China #Beijing #Merger_Agreement #LakeShore_Biopharma #Oceanpine_Skyline